1. ↑ Jump up to:1.0 1.1 Darras BT, Markowitz JA, Monani UR, De Vivo DC. Spinal muscular atrophies (2015) Neuromuscular Disorders of Infancy. Childhood, and Adolescence: A Clinician’s Approach.:117-45.
  2.  Genentech. Understanding Spinal Muscular Atrophy (SMA). Available from: (last accessed 7.6.2019)
  3.  Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. The Lancet Neurology. 2012 May 1;11(5):443-52.
  4.  Spinal muscular atrophy. Available from Last accessed 14/08/2022
  5.  Cure SMA. Learn to Spot the Warning Signs of SMA – Snapshot of Hallmark Symptoms (Video 9) Available from: [last accessed 31/01/2021]
  6.  Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 2010 Mar 9;74(10):833-8.
  7.  Ramsey D, Scoto M, Mayhew A, Main M, Mazzone ES, Montes J, de Sanctis R, Dunaway Young S, Salazar R, Glanzman AM, Pasternak A. Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool. PloS one. 2017 Feb 21;12(2):e0172346.
  8.  Wijnhoven TM, de Onis M, Onyango AW, Wang T, Bjoerneboe GE, Bhandari N, Lartey A, Rashidi BA. Assessment of gross motor development in the WHO Multicentre Growth Reference Study. Food and nutrition bulletin. 2004;25(1_suppl_1):S37-45.
  9.  Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Young SD, Salazar R, De Sanctis R, Pasternak A, Glanzman A, Coratti G. Revised upper limb module for spinal muscular atrophy: development of a new module. Muscle & nerve. 2017 Jun;55(6):869-74.
  10.  Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular Disorders. 2018 Feb 1;28(2):103-15.
  11.  Tiziano FD, Lomastro R, Pinto AM, Messina S, D’Amico A, Fiori S, Angelozzi C, Pane M, Mercuri E, Bertini E, Neri G. Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. Journal of medical genetics. 2010 Dec 1;47(12):856-8.
  12.  Passini MA, Cheng SH. Prospects for the gene therapy of spinal muscular atrophy. Trends in molecular medicine. 2011 May 1;17(5):259-65.
  13.  Harper JM, Krishnan C, Darman JS, Deshpande DM, Peck S, Shats I, Backovic S, Rothstein JD, Kerr DA. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proceedings of the National Academy of Sciences. 2004 May 4;101(18):7123-8.
  14. ↑ Jump up to:14.0 14.1 Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Muntoni F. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders. 2018 Mar 1;28(3):197-207.